Skip to main content
. 2011 Sep 22;2011:706746. doi: 10.1155/2011/706746

Table 1.

Clinical and laboratory data of healthy donors (C1–C12) and patients (Pt.1–Pt.3) contributing to serum samples for 2D-DIGE analysis.

ID Sex Serum sample Age (years) Total protein level (g/dL) Ig level (mg/dL) ERS (mm/1st h) CRP (mg/dL) Observed complications
IgG IgA IgM
C1 M 32 7 1400 250 150 14 0.35
C2 F 24 6.5 1100 200 80 14 0.33
C3 M P1 33 7 1200 180 85 18 0.33
C4 M 29 6.8 1180 300 98 11 0.36
C5 F 30 6.9 1110 100 100 7 0.4
C6 M 32 7.2 1300 180 110 7 0.35

C7 F 27 7 1280 270 70 4 0.30
C8 F 31 6.6 900 260 90 20 0.5
C9 M P2 30 6.8 980 360 180 2 0.5
C10 F 28 7.2 1160 220 150 4 0.35
C11 F 26 6.8 990 230 90 2 0.35
C12 F 27 7 1200 250 90 16 0.30

Pt. 1 M N1 33 6.2 7 6.1 10.5 9 <0.31 R, A
I1 34 7.5 400 6.1 10 20 0.5 R, A
Pt. 2 F N2 12 5.9 171 6.1 4.1 7 1 R
I2 13 6.5 350 6.1 6 14 0.5 R
Pt. 3 M N3 59 6.3 273 13.9 38 18 1.79 R, GI
I3 60 7 380 15 50 24 1.4 R, GI

ESR: erythrocyte sedimentation rate; CRP: C-reactive protein; R: respiratory tract infections; GI: gastrointestinal tract infections; A: autoimmunity.